With $27B plan to build 4 new plants, Eli Lilly doubles down on US drug manufacturing
Over the last few years, as Eli Lilly has revealed a series of manufacturing investments—each one seemingly more lavish than the last—the company’s spree has begged the question: What will they do | At a press conference in Washington,
Lilly plans to invest $27 billion in new US plants as Trump threatens pharmaceutical tariffs
Eli Lilly plans to spend at least $27 billion to build four new manufacturing plants in the U.S., the drugmaker said at a Washington press conference on Wednesday, as it grapples with the threat of drug import duties from the Trump administration.
Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the ...
17mon MSN
Apple’s decision this week to build a massive facility in Houston for making AI servers could mark a resurrection of the ...
For decades, manufacturing was a loaded word. But manufacturing is America’s comeback story. And in these divided times, it ...
Eli Lilly & Co.’s stock rose 1.6% Wednesday, after the drug company announced plans to expand its U.S. manufacturing sites by ...
Smith on Wednesday signed a deal — subject to regulatory approvals — to acquire metro Detroit-based Android Industries LLC ...
With global trade policies growing increasingly unpredictable, manufacturing businesses face the prospect of significant ...
Eli Lilly and Co. is in negotiations with several states and plans to announce the locations of four new manufacturing plants ...
The company is doubling plans for capital spending on U.S. factories as President Donald Trump pressures the pharma industry ...
Eli Lilly is building four new manufacturing sites, the drug company announced Wednesday, and though the $27 billion price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback